Letter to the Editor |
Centro SISA per lo Studio della Aterosclerosi, Ospedale Bassini, Cinisello Balsamo, Milano Department of Pharmacological Sciences, University of Milan Italy
To the Editor:
We read with interest the article by Ting et al1 showing that post-prandial triglyceride-rich lipoproteins (PP-TGRL) from healthy human volunteers (NTG) fail to promote endothelial inflammation but increase the tumor necrosis factor-
response of endothelial cells. We would like to add further information on this topic recently obtained in our laboratory2,3 that may contribute to the understanding of the role of TG-rich lipoproteins in modulating endothelial function(s).
Ting et al, showed that PP-TGRL are unable to elicit pro-inflammatory responses and this finding is based on the lack of effect of PP-TGRL on ICAM-1, VCAM-1 and E-selectin mRNA expression. An observation confirmed by the lack of monocyte recruitment by endothelial cells exposed to PP-TGRL. However, and consistent with our findings,2,3 postprandial TGRL per se activated p38MAPK a key pathway of intracellular signaling in inflammation.
In addition we showed that postprandial TGRL from type IV hyperlipidemic patients induce to a larger extent, compared with fasting TGRL, phosphorylation of p38 MAPK, CREB and IKB-
in human endothelial cells and increase the DNA binding activity of CREB, NFAT and NF-kB.3 These results prompted us to investigate the differences between PP-TGRL form NTG subjects and HTG patients on endothelial cell gene expression.2,4,5 We observed the induction by PP-TGRL form HTG patients but not by NTG subjects of a large set of proinflammatory genes including VCAM-1, PECAM-1, ELAM-1, ICAM-1, P-selectin, MCP-1, IL-6, TLR-4, CD40, ADAMTS1 and PAI-1. Furthermore, in vivo, the endothelium-dependent flow mediated dilatation (FMD) decreased in both NTG and HTG subjects after 4 hours from the intake of an oral fat load and returned to basal levels in NTG subjects while remained impaired in HTG subject up to 8 hours.3 Therefore only PP-TGRL from HTG patients modulated a proinflammatory gene set in endothelial cells.3
Thus our data suggest that in hypertriglyceridemic patients TGRL in the fasting state and more so in the post prandial phase may increase the endothelial dysfunction by inducing a proinflammatory activation of the endothelium. In normotriglyceridemic subjects accordingly to Ting et al1 the postprandial response only prime the endothelium toward a high sensitivity to a pro-inflammatory environment.
In conclusion we believe that the composition of TGRL that profoundly differs in hypertriglyceridemic patients versus normotriglyceridemic subjects is crucial and needs to be taken in account when discussing the effect of TG-rich lipoproteins on endothelial function.
References
1. Ting HJ, Stice JP, Schaff UY, Hui DY, Rutledge JC, Knowlton AA, Passerini AG, Simon SI. Triglyceride-rich lipoproteins prime aortic endothelium for an enhanced inflammatory response to tumor necrosis factor-
. Circ Res. 2007; 100: 381390.
2. Norata GD, Grigore L, Raselli S, Seccomandi PM, Hamsten A, Maggi FM, Eriksson P, Catapano AL. Triglyceride-rich lipoproteins from hypertriglyceridemic subjects induce a pro-inflammatory response in the endothelium: Molecular mechanisms and gene expression studies. J Mol Cell Cardiol. 2006; 40: 484494.[CrossRef][Medline] [Order article via Infotrieve]
3. Norata GD, Grigore L, Raselli S, Redaelli L, Hamsten A, Maggi F, Eriksson P, Catapano AL. Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies. Atherosclerosis. 2006. In press.
4. Norata GD, Pirillo A, Callegari E, Hamsten A, Catapano AL, Eriksson P. Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDL. Cardiovasc Res. 2003; 59: 169180.
5. Raw data on cDNA microarray experiments are available at the following address http://www.sisalombardia.it/dati/dati.htm.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |